Jessica Hurt

Company: Biogen Idec

Job title: Director, Genomic Targets Biology

Seminars:

Ataxin-2 ASO for the Treatment of Broad ALS 8:00 am

• Review learnings from prior ALS ASO programs • Present evidence supporting Ataxin-2 as a potential modifier of broad ALS • Development of an RNAseH-dependent ASO against Ataxin-2Read more

day: Day One AM

Kick-Off Panel Discussion Taking on CNS Disease with Oligonucleotides: What’s Hot? 7:30 am

Gathering together as the agenda kicks off to discuss the latest in technology, big oligo industry news, and excitement for the year aheadRead more

day: Day One AM